SCHEMBL23328672

SCHEMBL23328672

COC(=O)CNC(=N)Nc1ccc(C(F)(F)F)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
HTT P42858 2/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
TRPV1 Q8NER1 2/20 0.47
RAB9A P51151 2/20 0.46
MTOR P42345 2/20 0.46
MAPT P10636 1/20 0.46
KIF11 P52732 1/20 0.45
TGM2 P21980 1/20 0.45
NPC1 O15118 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
NAMPT P43490 1/20 0.45
BAZ1A Q9NRL2 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23328671 0.85 EPHX2 (0.54) EPHX2MEN1KMT2AHTTALDH1A1
SCHEMBL5112169 0.80 POLB (0.50) EPHX2MEN1KMT2AHTTALDH1A1
SCHEMBL25841022 0.79 FPR2 (0.49) EPHX2MEN1KMT2AHTTALDH1A1
SCHEMBL23328438 0.79 MEN1 (0.45) EPHX2MEN1KMT2AHTTALDH1A1
Hydrochloric Acid SCHEMBL5773679 0.78 POLB (0.49) EPHX2MEN1KMT2AHTTALDH1A1
SCHEMBL25841134 0.77 EPHX2 (0.51) EPHX2MEN1KMT2AHTTALDH1A1
SCHEMBL2945477 0.75 EPHX2 (0.58) EPHX2MEN1KMT2AHTTALDH1A1
SCHEMBL25841306 0.75 EPHX2 (0.49) EPHX2MEN1KMT2AHTTALDH1A1
SCHEMBL23328394 0.75 FPR2 (0.56) EPHX2MEN1KMT2AHTTALDH1A1
SCHEMBL23328894 0.75 CA12 (0.50) EPHX2MEN1KMT2ATRPV1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11701333-B2 Antibacterial compounds Kent Innovation & Enterprise (GB) 2023-07-18 US disclosed
US-20210128501-A1 ANTIBACTERIAL COMPOUNDS KENT INNOVATION & ENTERPRISE, UNIVERSITY OF KENT (GB) 2021-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11701333-B2 Antibacterial compounds ARF1, ARL1, TLR1 EPHX2 2581/4885MEN1 1300/4885KMT2A 2533/4885
US-20210128501-A1 ANTIBACTERIAL COMPOUNDS ARF1, ARL1, TLR1 EPHX2 2581/4885MEN1 1300/4885KMT2A 2533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.